Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-15,283
Closed -$20K 449
2018
Q3
$20K Buy
+15,283
New +$588K ﹤0.01% 429
2018
Q1
Sell
-16,337
Closed -$561K 258
2017
Q4
$561K Buy
+16,337
New +$557K ﹤0.01% 186
2017
Q1
Sell
-42,160
Closed -$1.3M 292
2016
Q4
$1.3M Hold
42,160
0.05% 127
2016
Q3
$1.35M Buy
+42,160
New +$1.41M 0.08% 114
2016
Q2
Sell
-3,162,000
Closed -$88.9M 278
2016
Q1
$88.9M Buy
3,162,000
+2,617,082
+480% +$74.8M 3.34% 8
2015
Q4
$16.7M Buy
+544,918
New +$17.1M 1.22% 16

Other funds holding PFE

Cowen Inc's PFE Position: Q4 2018 in Review

Cowen Inc sold out of Pfizer (PFE) in Q4 2018, closing a stake of 22 shares — an estimated $1K sold.

Cowen Inc first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $4.24M in Q2 2013. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Cowen Inc reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Cowen Inc sold 22 Pfizer shares in Q4 2018, an estimated $1K.
  • Cowen Inc first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
  • Cowen Inc's Pfizer position peaked at $4.24M in Q2 2013.
  • 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Cowen Inc's 13F filing for Q4 2018, filed 14 Feb 2019.